Biodistribution of Oncolytic Measles Virus after Intraperitoneal Administration into Ifnar™-CD46Ge Transgenic Mice

Human Gene Therapy

Volumn 14, Issue 16, 2003, Pages 1565-1577

  Peng, Kah Whye ^a   Frenzke, Marie ^a   Myers, Rae ^a   Soeffker, Diane ^a   Harvey, Mary ^a   Greiner, Suzanne ^a   Galanis, Evanthia ^a   Cattaneo, Roberto ^a   Federspiel, Mark J ^a   Russell, Stephen J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GREEN FLUORESCENT PROTEIN; IFNAR; INTERFERON RECEPTOR; MEMBRANE COFACTOR PROTEIN; ONCOLYTIC VIRUS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIAPHRAGM; EPITHELIUM; GENETIC TRANSFECTION; LYMPH NODE; MARKER GENE; MEASLES VIRUS; MESOTHELIUM; MOUSE; NONHUMAN; OMENTUM; OVARY; PERITONEAL CAVITY; PERITONEUM LAVAGE; PERITONEUM MACROPHAGE; SPLEEN; THORACIC DUCT; TISSUE SPECIFICITY; TRANSGENIC MOUSE; VIRUS INFECTION; VIRUS PARTICLE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD46; GREEN FLUORESCENT PROTEINS; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE I, RECOMBINANT; LUMINESCENT PROTEINS; MACROPHAGES; MEASLES VIRUS; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; PERITONEAL CAVITY; RECOMBINANT PROTEINS;

ANIMALIA; MEASLES VIRUS; MUS MUSCULUS; RNA VIRUSES;

EID: 10744219926     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403322495070     Document Type: Article

References (39)

1. AUWAERTER, P.G., ROTA, P.A., ELKINS, W.R., ADAMS, R.J., DELOZIER, T., SHI, Y., BELLINI, W.J., MURPHY, B.R., and GRIFFIN, D.E. (1999). Measles virus infection in rhesus macaques: Altered immune responses and comparison of the virulence of six different virus strains. J. Infect. Dis. 180, 950-958.
2. BEELEN, R.H.J. (1991). The greater omentum: Physiology and immunological concepts. Neth. J. Surg. 43, 145-149.
3. BUCHEIT, A.D., KUMAR, S., GROTE, D.M., LIN, Y., VON MESSLING, V., CATTANEO, R.B., and FIELDING, A.K. (2003). An oncolytic measles virus engineered to enter cells through the CD20 antigen. Mol. Ther. 7, 62-72.
4. CRANSHAW, M.L., and LEAK, L.V. (1990). Milky spots of the omentum: A source of peritoneal cells in the normal and stimulated animal. Arch. Histol. Cytol. 53(Suppl.), 165-177.
5. DOHERTY, N.S., GRIFFITHS, R.J., HAKKINEN, J.P., SCAMPOLI, D.N., and MILICI, A.J. (1995). Post-capillary venules in the "milky spots" of the greater omentum are the major site of plasma protein and leukocyte extravasation in rodent models of peritonitis. Inflamm. Res. 44, 169-177.
6. DORIG, R.E., MARCIL, A., CHOPRA, A., and RICHARDSON, C.D. (1993). The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295-305.
7. DUPREX, W.P., MCQUAID, S., HANGARTNER, L., BILLETER, M.A., and RIMA, B.K. (1999). Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J. Virol. 73, 9568-9575.
8. GROTE, D., RUSSELL, S.J., CORNU, T.I., CATTANEO, R., VILE, R., POLAND, G.A., and FIELDING, A.K. (2001). Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood 97, 3746-3754.
9. HAMMOND, A.L., PLEMPER, R.K., ZHANG, J., SCHNEIDER, U., RUSSELL, S.J., and CATTANEO, R. (2001). Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen. J. Virol. 75, 2087-2096.
10. HSU, E.C., DORIG, R.E., SARANGI, F., MARCIL, A., IORIO, C., and RICHARDSON, C.D. (1997). Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding. J. Virol. 71, 6144-6154.
11. HSU, E.C., IORIO, C., SARANGI, F., KHINE, A.A., and RICHARDSON, C.D. (2001). CDw150 (SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. Virology 279, 9-21.
12. KEMPER, C., LEUNG, M., STEPHENSEN, C.B., PINKERT, C.A., LISZEWSKI, M.K., CATTANEO, R., and ATKINSON, J.P. (2001). Membrane cofactor protein (MCP; CD46) expression in transgenic mice. Clin. Exp. Immunol. 124, 180-189.
13. KRAAL, G. (1992). Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132, 31-74.
14. KRAAL, G., and JANSE, M. (1986). Marginal metallophilic cells of the mouse spleen identified by a monoclonal antibody. Immunology 58, 665-669.
15. KRIST, L.F., EESTERMANS, I.L., STEENBERGEN, J.J., HOEFSMIT, E.C., CUESTA, M.A., MEYER, S., and BEELEN, R.H. (1995). Cellular composition of milky spots in the human greater omentum: An immunochemical and ultrastructural study. Anat. Rec. 241, 163-174.
16. LOPES CARDOZO, A.M., GUPTA, A., KOPPE, M.J., MEIJER, S., VAN LEEUWEN, P.A., BEELEN, R.J., and BLEICHRODT, R.P. (2001). Metastatic pattern of CC531 colon carcinoma cells in the abdominal cavity: An experimental model of peritoneal carcinomatosis in rats. Eur. J. Surg. Oncol. 27, 359-363.
17. MANCHESTER, M., and RALL, G.F. (2001). Model systems: Transgenic mouse models for measles pathogenesis. Trends Microbiol. 9, 19-23.
18. MRKIC, B., PAVLOVIC, J., RULICKE, T., VOLPE, P., BUCHHOLZ, C.J., HOURCADE, D., ATKINSON, J.P., AGUZZI, A., and CATTANEO, R. (1998). Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 72, 7420-7427.
19. MRKIC, B., ODERMATT, B., KLEIN, M.A., BILLETER, M.A., PAVLOVIC, J., and CATTANEO, R. (2000). Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J. Virol. 74, 1364-1372.
20. NANICHE, D., VARIOR-KRISHNAN, G., CERVONI, F., WILD, T.F., ROSSI, B., RABOURDIN-COMBE, C., and GERLIER, D. (1993). Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67, 6025-6032.
21. PENG, K.W., AHMANN, G.J., PHAM, L., GREIPP, P.R., CATTANEO, R., and RUSSELL, S.J. (2001). Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood 98, 2002-2007.
22. PENG, K.W., TENEYCK, C.J., GALANIS, E., KALLI, K.R., HARTMANN, L.C., and RUSSELL, S.J. (2002a). Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Cancer Res. 62, 4656-4662.
23. PENG, K.W., FACTEAU, S., WEGMAN, T., O'KANE, D., and RUSSELL, S.J. (2002b). Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides. Nat. Med. 8, 527-531.
24. PENG, K.W., DONOVAN, K.A., SCHNEIDER, U., CATTANEO, R., LUST, J.A., and RUSSELL, S.J. (2003). Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker. Blood 101, 2557-2562.
25. PHUONG, L.K., ALLEN, C., PENG, K.W., GIANNINI, C., GREINER, S., TENEYCK, C.J., MISHRA, P., MACURA, S.I., RUSSELL, S.J., and GALANIS, E. (2003). Use of a vaccine strain of measles virus genetically engineered to produce CEA as a novel therapeutic agent against glioblastoma multiforme. Cancer Res. 63, 2462-2469.
26. RADECKE, F., SPIELHOFER, P., SCHNEIDER, H., KAELIN, K., HUBER, M., DOTSCH, C., CHRISTIANSEN, G., and BILLETER, M.A. (1995). Rescue of measles viruses from cloned DNA. EMBO J. 14, 5773-5784.
27. RECOMBINANT DNA ADVISORY COMMITTEE. Recombinant DNA Advisory Committee Meeting, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, June 20-21, 2002. Protocol #0201-523: Phase I trial of intraperitoneal administration of an attenuated strain (Edmonston strain) of measles virus, genetically modified to produce carcinoembryonic antigen, in patients with recurrent ovarian cancer. Hum. Gene Ther. 13, 2220-2222.
28. ROSCIC-MRKIC, B., SCHWENDENER, R.A., ODERMATT, B., ZUNIGA, A., PAVLOVIC, J., BILLETER, M.A., and CATTANEO, R. (2001). Roles of macrophages in measles virus infection of genetically modified mice. J. Virol. 75, 3343-3351.
29. SALONEN, R., ILONEN, J., and SALMI, A. (1988). Measles virus infection of unstimulated blood mononuclear cells in vitro: Antigen expression and virus production preferentially in monocytes. Clin. Exp. Immunol. 71, 224-228.
30. SCHNEIDER, U., BULLOUGH, F., VONGPUNSAWAD, S., RUSSELL, S.J., and CATTANEO, R. (2000). Recombinant measles viruses efficiently entering cells through targeted receptors. J. Virol. 74, 9928-9936.
31. SCHNEIDER-SCHAULIES, S., and TER MEULEN, V. (2002). Triggering of and interference with immune activation: Interactions of measles virus with monocytes and dendritic cells. Viral Immunol. 15, 417-428.
32. SMITH, T.A., IDAMAKANTI, N., WRIGHT, P.M., MARSHALLNEFF, J., ROLLENCE, M.L., NEMEROW, G.R., MECH, C., PINKSTAFF, A., KALOSS, M., KALEKO, M., and STEVENSON, S.C. (2002). Heparan sulfate proteoglycans, and not CAR or integrins, are the major receptors for hepatic adenoviral transduction in vivo. Mol. Ther. 5, S149.
33. TATSUO, H., ONO, N., TANAKA, K., and YANAGI, Y. (2000). SLAM (CDw150) is a cellular receptor for measles virus. Nature 406, 893-897.
34. TSILIBARY, E.C., and WISSIG, S.L. (1987). Light and electron microscope observations of the lymphatic drainage units of the peritoneal cavity of rodents. Am. J. Anat. 180, 195-207.
35. TSUJIMOTO, H., HAGIWARA, A., SHIMOTSUMA, M., SAKAKURA, C., OSAKI, K., SASAKI, S., OHYAMA, T., OHGAKI, M., IMANISHI, T., YAMAZAKI, I., and TAKAHASHI, T. (1996), Role of milky spots as selective implantation sites for malignant cells in peritoneal dissemination in mice. J. Cancer Res. Clin. Oncol. 122, 590-595.
36. VAN BEUSECHEM, V.W., GRILL, J., MASTENBROEK, D.C., WICKHAM, T.J., ROELVINK, P.W., HAISMA, H.J., LAMFERS, M.L., DIRVEN, C.M., PINEDO, H.M., and GERRITSEN, W.R. (2002). Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished. J. Virol. 76, 2753-2762.
37. WIJFFELS, J.F., HENDRICKX, R.J., STEENBERGEN, J.J., EESTERMANS, I.L., and BEELEN, R.H. (1992). Milky spots in the mouse omentum may play an important role in the origin of peritoneal macrophages. Res. Immunol. 143, 401-409.
38. YUAN, Z., RODELA, H., HAY, J.E., OREOPOULOS, D., and JOHNSTON, M.G. (1994). Lymph flow and lymphatic drainage of inflammatory cells from the peritoneal cavity in a casein-peritonitis model in sheep. Lymphology 27, 114-128.
39. ZHU, H., NAITO, M., UMEZU, H., MORIYAMA, H., TAKATSUKA, H., TAKAHASHI, K., and SHULTZ, L.D. (1997). Macrophage differentiation and expression of macrophage colony-stimulating factor in murine milky spots and omentum after macrophage elimination. J. Leukoc. Biol. 61, 436-444.